Targeting B cells for inflammatory bowel disease treatment: back to the future

T Castro-Dopico, JF Colombel, S Mehandru - Current opinion in …, 2020 - Elsevier
B cells are critical to immune homeostasis at mucosal surfaces including those of the
gastrointestinal tract. B cell-related abnormalities, comprising of a lympho-plasmacytic …

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

J Torres, J Hu, A Seki, C Eisele, N Nair, R Huang… - Gut, 2020 - gut.bmj.com
Background and aims Prenatal and early life bacterial colonisation is thought to play a major
role in shaping the immune system. Furthermore, accumulating evidence links early life …

Role of B-cell activating factor (BAFF) in inflammatory bowel disease

M Kumric, PM Zivkovic, T Ticinovic Kurir, J Vrdoljak… - Diagnostics, 2021 - mdpi.com
As early commencement of inflammatory bowel disease (IBD) treatment has been shown to
substantially improve outcomes, it is of utmost importance to make a timely diagnosis of this …

BAFF Blockade Attenuates DSS-Induced Chronic Colitis via Inhibiting NLRP3 Inflammasome and NF-κB Activation

Y Zhang, M Tao, C Chen, X Zhao, Q Feng… - Frontiers in …, 2022 - frontiersin.org
Background BAFF production is increased in IBD patients. However, the specific role of
BAFF in IBD is still uncovered. This study aimed to investigate the expression and function of …

[HTML][HTML] Expression levels of 4 genes in colon tissue might be used to predict which patients will enter endoscopic remission after vedolizumab therapy for …

B Verstockt, S Verstockt, M Veny, J Dehairs… - Clinical …, 2020 - Elsevier
Background & Aims We aimed to identify biomarkers that might be used to predict responses
of patients with inflammatory bowel diseases (IBD) to vedolizumab therapy. Methods We …

Dual B-cell targeting therapy ameliorates autoimmune cholangitis

W Zhang, T Shao, PSC Leung, K Tsuneyama… - Journal of …, 2022 - Elsevier
Objective The ability to regulate B cell development has long been recognized to have
therapeutic potential in a variety of autoimmune diseases. However, despite the presence of …

Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation

Y Fu, L Wang, C Xie, K Zou, L Tu, W Yan, X Hou - Scientific reports, 2017 - nature.com
Faecal calprotectin and faecal occult blood test (FOBT) were widely used in the diagnosis
and assessment of intestinal inflammation in inflammatory bowel disease (IBD). Recently we …

Chlorogenic Acid Inhibits BAFF Expression in Collagen‐Induced Arthritis and Human Synoviocyte MH7A Cells by Modulating the Activation of the NF‐κB Signaling …

X Fu, X Lyu, H Liu, D Zhong, Z Xu… - Journal of …, 2019 - Wiley Online Library
B cell activating factor (BAFF), a member of the tumor necrosis factor (TNF) family, plays a
critical role in the pathogenesis and progression of rheumatoid arthritis (RA). Chlorogenic …

BAFF produced by neutrophils and dendritic cells is regulated differently and has distinct roles in antibody responses and protective immunity against West Nile virus

D Giordano, R Kuley, KE Draves, K Roe… - The Journal of …, 2020 - journals.aai.org
B cell activating factor (BAFF) is essential for B cells to develop and respond to Ags.
Dysregulation of BAFF contributes to the development of some autoimmune diseases and …

B cell class switching in intestinal immunity in health and disease

A Fleming, T Castro‐Dopico… - Scandinavian journal of …, 2022 - Wiley Online Library
The gastrointestinal tract is colonized by trillions of commensal microorganisms that
collectively form the microbiome and make essential contributions to organism homeostasis …